Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR
Megan Schwarz(Icahn School of Medicine at Mount Sinai), Seunghee Kim‐Schulze(Icahn School of Medicine at Mount Sinai), Kemuel Nunez(Icahn School of Medicine at Mount Sinai), Juan Manuel Carreño(Icahn School of Medicine at Mount Sinai), Isabel Cervera(Instituto de Salud Carlos III), Vanessa Barcessat(Icahn School of Medicine at Mount Sinai), M. Cecilia Berin(Northwestern University), Kevin Tuballes(Icahn School of Medicine at Mount Sinai), Cristóbal Belda-Iniesta(Instituto de Salud Carlos III), María González-Pérez(Instituto de Salud Carlos III), Kevin Mohammed(Icahn School of Medicine at Mount Sinai), Daniel Lozano‐Ojalvo(Child Health and Development Institute), Jessica Ho(Icahn School of Medicine at Mount Sinai), Denis Torre(Icahn School of Medicine at Mount Sinai), Arvin C. Dar(Memorial Sloan Kettering Cancer Center), Carmen Cámara(Universidad Complutense de Madrid), Manishkumar Patel(Icahn School of Medicine at Mount Sinai), José Pórtoles(Hospital Universitario Puerta de Hierro Majadahonda), Rafael Correa‐Rocha(Hospital General Universitario Gregorio Marañón), Jocelyn Harris(Icahn School of Medicine at Mount Sinai), Tommaso Tabaglio(Agency for Science, Technology and Research), Lorenzo Colombo(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Marcos López‐Hoyos(Universidad de Cantabria), William M. Marsiglia(University of Alabama at Birmingham), Rodrigo Sánchez-Tarjuelo(Instituto de Salud Carlos III), Anthony T. Tan(Duke-NUS Medical School), Saboor Hekmaty(Icahn School of Medicine at Mount Sinai), Alberto Ortíz(Hospital Universitario Fundación Jiménez Díaz), Irene Bodega‐Mayor(Instituto de Salud Carlos III), Giuseppe Nicoletti, Isabella Della Noce, Jesús Oteo(Instituto de Salud Carlos III), Sandra Hatem(Icahn School of Medicine at Mount Sinai), Antonio J. Carcas(Hospital La Paz Institute for Health Research), Miriam Mérad(Icahn School of Medicine at Mount Sinai), Florian Krammer(Icahn School of Medicine at Mount Sinai), Nina Le Bert(Duke-NUS Medical School), Joey Ming Er Lim(Duke-NUS Medical School), Robert Sebra(Mount Sinai Hospital), Sacha Gnjatic(Tisch Hospital), Slim Mzoughi(Icahn School of Medicine at Mount Sinai), Graziano Santoro(University of Brescia), Maurizio Ferrari(San Raffaele University of Rome), Patricia Conde(Instituto de Salud Carlos III), Eduardo López‐Granados, Cristina Lapucci(Synesis), Estela Paz‐Artal(Universidad Complutense de Madrid), Alberto M. Borobia(Hospital La Paz Institute for Health Research), Kai Nie(Icahn School of Medicine at Mount Sinai), Jesús Frías(Baylor College of Medicine)
Cited by 45
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
|New England Journal of Medicine|2012|2.1k
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
|Blood|2016|1.6k
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
|Nature Reviews Clinical Oncology|2021|1.5k